PCN82 Pharmacoeconomical Evaluation of Multiple Mieloma Treatment With Lenalidomide in the Russian Federation

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.1199
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment Outcomes of Regimens Containing Delamanid Within Therapy of Multiple and Extensive Drug Resistant Tuberculosis in the Russian Federation

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2019English

Pharmacoeconimic Analysis of Continuous Subcutaneous Insulin Infusion Compared With Multiple Daily Injection in the Treatment of Patients With Type 1 Diabetes Mellitus in the Russian Federation

Pharmacoeconomics: theory and practice
2019English

The Efficacy of Calcineurin Inhibitor Produced in the Russian Federation in Treatment of Patients With Atopic Dermatitis

Klinicheskaya Dermatologiya i Venerologiya
DermatologyInfectious Diseases
2018English

Russian Federation

IMF Staff Country Reports
2018English

Russian Federation

IMF Staff Country Reports
2018English

Russian Federation

Education at a Glance
2013English

Characteristics’ Evaluation of the Dissemination of Social Innovations Process in the Russian Federation

2017English

Budget Impact Evaluation of Treatment With a Low Protein Diet and Ketoanalogues of Essential Aminoacids for Predialysis Patients in Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Update on the Role of Lenalidomide in Patients With Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy